Literature DB >> 26367112

MiR-634 decreases cell proliferation and induces apoptosis by targeting mTOR signaling pathway in cervical cancer cells.

Jianglin Cong1,2, Riming Liu3, Xuan Wang2, Haiyang Jiang2, Youzhong Zhang1.   

Abstract

Taking the emergence of continuous resistance to chemotherapy and the evidence that miRNAs are associated with chemoresistance in cancers into consideration, it is of significant importance to reveal the miRNAs functions for the treatment of cancer. As a novel tumor suppressor, MiR-634 is known to induce apoptosis in tumor cell which is essential for tumorigenesis. Herein, we elucidated the regulation effects of miR-634 in gene expression and discovery of its target gene in cell proliferation and invasion that would aid therapeutic apoptosis. As a result, by targeting mTOR signal pathway, miR-634 inhibited cell proliferation, migration and invasiveness in cervical cancer cells and the block of miR-634 enhances the mTOR expression at both the mRNA and protein levels which regulated the expression of mTOR negatively. Taken together, these results further indicated that miR-634 is an effective target for cancer treatment, and the findings provided in this work might lead to the better understanding of the malignant behavior of cervical carcinoma.

Entities:  

Keywords:  cell proliferation; cervical cancer; mTOR expression; microRNA

Mesh:

Substances:

Year:  2015        PMID: 26367112     DOI: 10.3109/21691401.2015.1080171

Source DB:  PubMed          Journal:  Artif Cells Nanomed Biotechnol        ISSN: 2169-1401            Impact factor:   5.678


  16 in total

Review 1.  MicroRNAs in gynecological cancers: Small molecules with big implications.

Authors:  Sanjeev K Srivastava; Aamir Ahmad; Haseeb Zubair; Orlandric Miree; Seema Singh; Rodney P Rocconi; Jennifer Scalici; Ajay P Singh
Journal:  Cancer Lett       Date:  2017-05-24       Impact factor: 8.679

2.  Hsa_circ_0081069 facilitates tongue squamous cell carcinoma progression by modulating MAP2K4 expression via miR-634.

Authors:  Chao Pan; Zhijian Su; Honghui Xie; Yanyang Ning; Shuangjing Li; Haibo Xiao
Journal:  Odontology       Date:  2022-10-01       Impact factor: 2.885

3.  miR-634 exhibits anti-tumor activities toward hepatocellular carcinoma via Rab1A and DHX33.

Authors:  Chris Zhiyi Zhang; Yun Cao; Jia Fu; Jing-Ping Yun; Mei-Fang Zhang
Journal:  Mol Oncol       Date:  2016-09-20       Impact factor: 6.603

Review 4.  Role of microRNAs in epidermal growth factor receptor signaling pathway in cervical cancer.

Authors:  Nima Hemmat; Ahad Mokhtarzadeh; Mohammad Aghazadeh; Farhad Jadidi-Niaragh; Behzad Baradaran; Hossein Bannazadeh Baghi
Journal:  Mol Biol Rep       Date:  2020-05-07       Impact factor: 2.742

5.  LncRNA DANCR functions as a competing endogenous RNA to regulate RAB1A expression by sponging miR-634 in glioma.

Authors:  Dawei Xu; Jian Yu; Guojun Gao; Guangjian Lu; Yi Zhang; Pengju Ma
Journal:  Biosci Rep       Date:  2018-02-02       Impact factor: 3.840

Review 6.  MicroRNAs in Neurocognitive Dysfunctions: New Molecular Targets for Pharmacological Treatments?

Authors:  Wissem Deraredj Nadim; Viorel Simion; Helene Benedetti; Chantal Pichon; Patrick Baril; Severine Morisset-Lopez
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

7.  Expression of miR-634 in gastric carcinoma and its effects on proliferation, migration, and invasion of gastric cancer cells.

Authors:  Jiao Guo; Chun-Dong Zhang; Jia-Xiang An; Yun-Yun Xiao; Shuai Shao; Nuo-Ming Zhou; Dong-Qiu Dai
Journal:  Cancer Med       Date:  2018-02-21       Impact factor: 4.452

8.  MiR-634 sensitizes glioma cells to temozolomide by targeting CYR61 through Raf-ERK signaling pathway.

Authors:  Zhigang Tan; Jizong Zhao; Yugang Jiang
Journal:  Cancer Med       Date:  2018-02-23       Impact factor: 4.452

Review 9.  mTOR signaling-related MicroRNAs and Cancer involvement.

Authors:  Ping Wang; Xiao-Min Liu; Lei Ding; Xin-Ju Zhang; Zhong-Liang Ma
Journal:  J Cancer       Date:  2018-01-08       Impact factor: 4.207

10.  Specific miRNA expression profile in the blood serum of cardiac myxoma patients.

Authors:  Liangliang Yan; Jiahui Li; Qingsong Wu; Liangwan Chen
Journal:  Oncol Lett       Date:  2018-07-25       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.